|
|
|
Volumn 316, Issue 7126, 1998, Pages 227-
|
|
Regulating the pharmaceutical industry. Australian scheme has disadvantages.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AUSTRALIA;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG INDUSTRY;
ECONOMICS;
HUMAN;
NOTE;
UNITED KINGDOM;
AUSTRALIA;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
DRUG INDUSTRY;
GREAT BRITAIN;
HUMANS;
|
|
EID: 0032539323
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
